Objective To characterize the implementation of hypothermia for neonatal hypoxic ischemic
encephalopathy (HIE) in a population-based cohort. Study design Using the California …

Neonatal encephalopathy affects 2 to 5 of every 1000 live births and represents a major
cause of mortality and long-term morbidity in affected infants. Hypoxic ischemic …

Objective To characterize variations in practices and outcomes for neonates with hypoxic-
ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian …

Objective The use of therapeutic hypothermia (TH) for mild hypoxic–ischaemic
encephalopathy (HIE) remains controversial and inconsistent. We analysed trends in TH …

Introduction: Accurately diagnosing and treating infants with mild forms of hypoxic ischemic
encephalopathy (HIE) is important, as the majority of neonates with signs and symptoms of …

BACKGROUND: Birth asphyxia in term neonates remains a serious condition that causes
significant mortality and longterm neurodevelopmental sequelae despite hypothermia …

Evidence suggests that hypothermia for hypoxic ischemic encephalopathy in the term
neonate may decrease the risk of death or neurodevelopmental impairment. The objective of …

Background and aim The benefits of therapeutic hypothermia have not been assessed from
the perspective of the neurology clinic. We aimed to report the impact of the implementation …

Context: Therapeutic hypothermia is the recommended treatment for neonates with
moderate or severe hypoxic ischemic encephalopathy (HIE). There is an increasing trend to …

Objective To compare the characteristics and outcomes of neonates with mild hypoxic-
ischemic encephalopathy (HIE) who received hypothermia versus standard care. Study …